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Abstract
The aim of this study was to evaluate injectable, in situ cross-linkable elastin-like recombinamers
(ELRs) for osteochondral repair. Both the ELR-based hydrogel alone and the ELR-based hydrogel em-
bedded with rabbit mesenchymal stromal cells (rMSCs) were tested for the regeneration of critical
subchondral defects in 10 New Zealand rabbits. Thus, cylindrical osteochondral defects were filled
with an aqueous solution of ELRs and the animals sacrificed at 4 months for histological and gross
evaluation of features of biomaterial performance, including integration, cellular infiltration, sur-
rounding matrix quality and the new matrix in the defects. Although both approaches helped carti-
lage regeneration, the results suggest that the specific composition of the rMSC-containing hydrogel
permitted adequate bone regeneration, whereas the ELR-based hydrogel alone led to an excellent re-
generation of hyaline cartilage. In conclusion, the ELR cross-linker solution can be easily delivered
and forms a stable well-integrated hydrogel that supports infiltration and de novo matrix synthesis.
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Introduction
Chondral and osteochondral defects in the articular cartilage of
the knee and in other joints caused by traumatic and non-traumatic
injuries tend to progress to degenerative osteoarthritis over time.
This scenario usually leads to total replacement of the joint with
prosthesis [1]. Several types of cartilage are known, including the ar-
ticular hyaline cartilage, which is a smooth, pearly bluish layer with
a width of 2–4 mm that covers the articular surfaces [2]. Articular
hyaline cartilage is a highly specialized tissue characterized by its
unique mechanical properties [2]; it has a structural role adsorbing
the pressure overload the cartilage, and a functional role allowing
the friction-less sliding of the articular surface [3, 4]. When the carti-
lage layer is damaged, the structural components of hyaline cartilage
(proteoglycans and glycosaminoglycans) tend to leak from it,
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reducing the ability to absorb the pressure overload [5].
Consequently, the functional capacity of friction-less sliding
decreases, indeed, due to the remodeling of the layer, the water dif-
fusion into the cartilage is reduced. Hyaline cartilage diseases bring
synovitis, which progress to the inflammation of the articular layer
[6]. In mammals, the ability of articular cartilage to durably repair
decreases soon after birth and is almost completely lost by early
adulthood [7]. Generally, the regenerated cartilage is rich in type I
collagen (fibrocartilage) instead of containing type II collagen.
Collagen type II provides tensile ability to the cartilaginous matrix
and is essential for articular hyaline functional capacities [8],
whereas fibrocartilage is unable to maintain the biomechanical char-
acteristics of articular cartilage [2, 4, 5]. All treatments currently
used to restore the hyaline articular surface are unsatisfactory [2], al-
though several alternatives have been probed to promote the regen-
eration of damaged cartilage. In particular, the development of
novel tissue-engineering methods has started to play an important
role [9, 10]. Mesenchymal stromal cell (MSC) therapy [11–13] is a
method that utilizes pluripotent cells, which can differentiate into
various cell types, such as chondrocytes and osteocytes. As a result,
these cells are good candidates for the treatment of musculoskeletal
lesions [14, 15]. MSCs are available from different auto-, allo- and
xenogeneic sources [16]. The first two options offer an immunologi-
cally safer approach, whereas the latter hugely increases the avail-
ability of MSCs [17]. Although there are several studies with
successful results using xenogeneic MSCs in different animal hosts
[18], only autologous [19] or allogenic cells [13] have been success-
fully used in humans, with negligible immunological response [20].
Moreover, in the case of osteochondral application, it must be taken
into account that articular cartilage is considered an immunoprivi-
leged tissue, indeed, due to its avascularity, the immune system has
some limitations for the detection of implanted tissue [21]. The sus-
pension of MSCs in a scaffold as a cell-carrier enhances the persis-
tence of the implanted cells at the treatment site [2]. Taking
into account that the majority of wet articular cartilage is formed by
water [22], hydrogels represent one of the most promising solutions
for cartilage repair applications. Moreover, it is important to
consider that, during surgery, it is crucial to minimize the severity of
the intervention [23]. One advantage of the arthroscopic technique
is that it can reduce infection risk and recovery time compared to
open joint surgery. In light of this, the use of injectable hydrogels is
of special interest because they are compatible with arthroscopic
methods [23].
The use of recombinant DNA techniques has brought new
materials to the biomedical field, discovering new matrices for tissue
engineering (TE) applications. An important role is played by
elastin-like recombinamers (ELRs); they are based on the repetitive
pentapeptide sequence ValProGlyXGly (VPGXG)n, where
the guest residue (X) is any amino acid except L-proline [24]. The
thermosensitivity shown by ELRs is defined by the transition tem-
perature (Tt). It depends on the charge of protein conformations and
on the polarity of the amino acids that composed the ELRs [25, 26].
Moreover, a great advantage of the ELRs is the ability to form
different structures, among which a hydrogel is one of the most
common for regenerative medicine application [9]. As pointed
out above, the ELRs show thermosensitivity, thus meaning that
hydrogels, which are stable at body temperature, can be formed
whenever the Tt of the ELR is lower than this temperature [27].
Several studies have shown how different types of ELRs can be used
in some of the most challenging fields of tissue regeneration, such as
cardiovascular [28], ocular prosthesis [29] and osteochondral appli-
cations [30, 31], among others [27].
The incorporation of cells into biomaterials can help to over-
come some limitations of using cells or biomaterials alone. For
instance, an ELR-based hydrogel can serve as a scaffold to allow
MSCs to orchestrate tissue regeneration. Moreover, considering
the extraordinary compatibility of ELRs, the 3D hydrogel structure
can mimic the properties of the extracellular matrix (ECM), thereby
supporting the regeneration process.
In this study, in order to promote cell attachment and stimulate
matrix production, we developed an appropriate ELR-based bioac-
tive hydrogel composition that provides an adequate balance of
properties, such as mechanical support [32], to foster cell adhesion
and proliferation. Given their recombinant nature, ELRs were
designed to contain bioactive sequences, such as the extensively
studied RGD sequence, which supports cell adhesion via integrins
[33], CS5 human fibronectin REDV for efficient cell attachment
[28, 34] and VGVAPG as an elastase target domain (human leuko-
cyte elastase I) to provide increased proteolytic sensitivity and
increased functionality to the scaffold [35, 36]. In this study, we
obtained a homogeneous embedding of rabbit MSCs (rMSCs) in the
ELR solution at a temperature below body temperature, and
injected this composition as a cell-scaffold system for osteochondral
repair. This ELR-based bioactive hydrogel exhibited a cell-friendly




All procedures regarding the collection of rMSCs specified below
were approved by the Ethics Committee of the University Hospital
of Valladolid (Spain) in accordance with the Declaration of Helsinki
(1975), as revised in 2013. All animal experiments were conducted
in accordance with the institutional guidelines for the care and
use of experimental animals of the University of Valladolid (Spain)
in accordance with Directive 2010/63/EU (Resolution Number
2010/2/23).
Rabbit mesenchymal stem cell collection
Bone marrow was extracted from the tibias and fibulas of white
New Zealand male rabbits and collected in sterile tubes (FalconV
R
A
Corning Brand, Ref. 352070) previously damped with a heparinized
saline solution of Phosphate Buffered Saline (PBS, Gibco Ref.
20012-068) and 5% Heparin Sodium (Chiesi Spain S.A.U) to avoid
coagulation. Bone marrow samples were kept at 4C until they were
processed within 24 h. A fraction of mononuclear cells (MNCs) was
selected using a density gradient method with Ficoll-Paque
PREMIUM (GE Healthcare Ref. 17-5442-02). At the end of this
process, counting and viability controls were performed using the
Trypan Blue exclusion method with a Neubauer Chamber. After the
selection process, MNCs were seeded at a density of 190103 cells/
cm2 and kept in culture at 37C and 10% CO2 with Dulbecco’s
modified Eagle medium (DMEM) 4.5 g/l D-glucose (Gibco, Ref.
31966-021) supplemented with 0.041 mg/ml of gentamicin (Gibco,
Ref. 15710-049) and 20% Fetal Bovine Serum (FBS, Gibco). Every
3 or 4 days, the appearance of the cell monolayer was observed with
an inverted microscope and the percentage growth recorded. If con-
fluence was <60–80%, a change of medium was performed until











artinez on 16 February 2021
cells covered 80% surface of culture. Then, dissociation and cellular
expansion (passage) were carried out and the subcultures developed
in order to increase and purify the MSC cell line. The cells obtained
during this first step were cryopreserved in FBS and 10% DMSO
(Dimethyl sulfoxide, Sigma Ref. D2650), and stored in liquid nitro-
gen at 196C. Then, when the cells were needed for the assays,
they were thawed at 37C, seeded at a density of 1000 cells/cm2 and
kept in culture for 7–10 days before use, changing the medium ev-
ery 3 or 4 days.
ELR biosynthesis and purification
The gene construction was performed by molecular biology and re-
combinant DNA technique following standard methods previously
described [37, 38]; the purification process was carried out by sev-
eral centrifugations preceded by inverse transition cycling. The
ELRs obtained in this manner were dialyzed against MilliQ water
and lyophilized. Three ELRs extensively studied by Gonzalez et al.,
namely VKVx24, HRGD6 and REDV, were employed in this study
[28] (Fig. 1). HRGD6 was designed to contain the extensively stud-
ied RGD sequence, which supports cell adhesion via integrins;
REDV was designed to contain bioactive sequences such as the CS5
human fibronectin REDV for efficient cell attachment and
VGVAPG as an elastase target domain (human leukocyte elastase I).
The ELRs were further characterized by electrophoresis gel
(SDS-PAGE), mass spectroscopy (MALDI-TOF), nuclear magnetic
resonance (NMR), infrared spectroscopy (FTIR) and differential
scanning calorimetry (DSC) [39]. The ELRs obtained were chemi-
cally modified and characterized by transformation of the -amine
group in the lateral lysine chain to produce the cyclooctyne and
azide groups necessary for subsequent ‘click chemistry’ reactions, as
reported previously [28, 40]. The characterization results are pro-
vided in the Supplementary Figs S1–S9.
Gel formation
Freeze-dried ELRs were dissolved in plain DMEM for 16 h at 4C at
a concentration of 75 mg/ml. The ELR-cyclooctyne solution com-
prised entirely VKVx24-cyclo, whereas the ELR-azide solution com-
prised REDV-N3 and HRGD6-N3 (in equal amounts). To prepare
the hydrogel embedded with rMSCs, the cells were mixed with the
solution of VKVx24-cyclo and dissolved in neat DMEM at 4C. For
gel formation, cold solutions of VKVx24-cyclo and REDV-N3 and
HRGD6-N3 were mixed together and the gel formed using catalyst-
free click reactions between an azide group and an activated cyclo-
octyne group.
Rheological characterization
Rheological experiments were performed using a strain-controlled
AR-2000ex rheometer (TA Instruments) with the hydrogel sub-
merged in water. Cylindrical swollen gel samples were placed be-
tween parallel, non-porous stainless steel plates (diameter¼12 mm).
The gap between the plates was adjusted by applying the minimum
normal force to prevent slippage. Before the measurements started,
all the samples were relaxed until equilibrium; the temperature was
controlled and maintained at 37C using a Peltier device. Shear
deformation measurements were carried out. The dynamic shear
modulus was measured by performing a dynamic strain sweep with
amplitudes having a range between 0.1 and 20% at a fixed
frequency of 1 Hz. Thus, the linear region of viscoelasticity was de-
termined. Afterward, a dynamic frequency sweep was carried out
between 0.05 and 70 Hz at a fixed strain amplitude (1%), thus the
dependence of the dynamic shear modulus and the loss factor on the
frequency was obtained. Finally, the rheological characterization
presented the storage modulus and the loss modulus, G0 and G00
respectively. As a results of those, the magnitude of the complex
modulus |G*| (|G*|2¼ (G0)2þ (G00)2), and the loss factor (tan
d (G00)/(G0), where d is a function of frequency or strain amplitude)
were calculated.
Scanning electron microscopy
The morphology of the hydrogel was investigated by scanning elec-
tron microscopy (SEM) using a FEI Quanta 200 FEG instrument.
No coating procedures were used during the sample preparation;
briefly, hydrated hydrogels were submerged into liquid nitrogen,
mechanically fractured and freeze-dried. Afterwards, the pictures
were collected using the microscope at Landing E of 7.00 keV and a
pressure of 0.7 Torr and finally the images were analysed using
Image-J software.
Cell viability assay
The viability of isolated rMSCs embedded in ELRs at 75 mg/ml was
evaluated using the Alamar Blue assay (Invitrogen) according to the
manufacturer’s guidelines. Briefly, rMSCs were isolated according
to the protocol described above and mixed with the hydrogels at a
concentration of 8 million cells/ml. A 100-ll aliquot was then pipet-
ted into a 24-well TranswellV
R
tissue culture plate. After allowing the
Figure 1. Graphical scheme of the ELR compositions: (A) VKVx24; (B) HRGD6; (C) REDV
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cells to adapt for 4 h, the hydrogels were washed twice with PBS and
metabolic activity measurements were conducted at 0, 3, 6, 9, 12
and 15 days of culture. For this purpose, 2 ml of a DMEM-
containing 10% Alamar Blue solution was used to replace the cul-
ture medium and the cells were incubated in darkness for 2 h at
37C and under a 5% CO2 atmosphere. Subsequently, 70ml of the
reduced medium was transferred to a 96-well plate. The hydrogels
were washed twice with PBS and the corresponding growth medium
was added and incubated again in order to determine the metabolic
activity at different times. Fluorescence (excitation: 560 nm; emis-
sion 590 nm) was measured using a SpectraMax M5e (Molecular
Devices) microplate reader [41]. The fluorimetric reduction of 10%
Alamar Blue reagent in the culture medium by the cells was mea-
sured at regular time intervals. Samples for the phase-contrast epi-
fluorescence were fixed at 4% paraformaldehyde (Sigma-Aldrich)
for 40 min. Staining was carried out after permeabilization of the
sample with 0.2% Triton X-100 (Sigma-Aldrich) and stained with
the fluorescent dyes Phalloidin–Alexa Fluor488R and DAPI
(Invitrogen).
In vivo experimental model
Ten female New Zealand white rabbits with an age of 6 months and
an average weight of 3 kg were used for the creation and treatment
of the osteochondral defects. The number of animals was deter-
mined by power analysis and consideration of previous studies [42–
44], following the 3Rs principles formulated by Russell and Burch
for animal experimentation [45]. The animals were anesthetized in-
tramuscularly with medetomidine (0.5 mg/kg) (Braun) and ketamine
(25 mg/kg) (Richter Pharma). Afterward, both knees were shaved
and cleaned. The surgical procedure involved a parapatellar incision
of the skin, which was performed under sterile conditions in order
to expose the distal femur. A critical-size (44 mm full-thickness)
osteochondral lesion was created with a drill (Fig. 2A), following
well-established surgical procedures [46–49]. The defect was deep
enough to reach the osteochondral bone. The ELR-cyclooctyne and
ELR-azide solutions were then mixed together and the cold solution
(below Tt) was pipetted completely into the defect (Fig. 2B). The gel
was immediately formed by a catalyst-free click reactions between
the azide group and activated cyclooctyne groups, filling the lesion
created with the drill entirely (Fig. 2C). Each animal was surgically
operated at both knees and hydrogels with and without rMSCs em-
bedded were pipetted into the right/left knee defects at random.
Carprofen (50 mg/kg) (Norbrook) was administrated 4 h after the
surgical procedure. All animals were fed and watered ad libitum
during the study period and maintained in individual cages. Animals
were euthanized intravenously with pentobarbital (200 mg/kg) at
4 months post-treatment and the distal femora extracted for further
analysis [17].
Gross morphology
The entire knees of each rabbit were dissected and the distal part of
each femur was extirpated. Samples for each group were photo-
graphed and examined for evaluation as per the International
Cartilage Repair Society (ICRS) gross morphology assessment scale
for cartilage repair [50, 51].
Histological analysis
A blind macro- and microscopic analysis was performed by trained
histologists for all the samples previously fixed in 4% formaldehyde
in PBS 0.05 M (pH 7.3) at 4C. The sections were stained with sev-
eral stains: Hematoxylin and Eosin (H&E), Picro-Sirius Red Stain
and Safranin-O/Fast Green, for collagen and glycosaminoglycan
(GAGs) stains, respectively. The staining procedures were performed
according to common methods. Moreover, immunohistochemistry
was performed with primary antibody Mouse monoclonal anti-
collagen type I and anti-collagen type II. Samples from each rabbit
(n¼10 for each group) were graded by two observers using the
ICRS visual histological assessment scale for cartilage repair [52].
Statistical analysis
Values are expressed as mean6standard deviation. Statistical analy-
sis was evaluated by one-way analysis of variance using the Tukey’s
method. P-values <0.05 was considered statistically significant.
Results
Rheological characterization
The linear viscoelastic region of the ELR hydrogels comprising 50%
VKVx24-cyclo, 25% REDV-N3 and 25% HRGD6-N3 at 75 mg/ml
was determined by using strain sweep measurements from 0.01 to
20% strain at a frequency of 1 Hz (Fig. 3A). The complex modulus
(|G*|) at 75 mg/ml shows a constant value of 964 6 156 Pa (at 1%
strain) in this strain range. As such, a 1% strain was selected to carry
out the dynamic frequency sweep measurements. Evolution of the
storage (G0) and loss moduli (G00) is represented in Fig. 3B. At a fre-
quency of 1 Hz, the value of G0 is 960 6 162 Pa, whereas the value
of G00 is 28 6 19 Pa. Moreover, the evolution of d as a function of
the frequency is represented in Fig. 3C (the value of d at 1 Hz is
1.6 6 0.9).
Figure 2. (A) Creation of the osteochondral defect with critical size; (B) pipetting of the ELR solutions with and without cells embedded inside the defect; (C) forma-
tion of the gel via a catalyst-free click reaction, thereby entirely filling the lesion created
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SEM
ELR hydrogels at 75 mg/ml show a porous environment, with pore
sizes ranging from around 3 to 20mm and a wall thickness of
1.11 6 0.34mm (Fig. 4). This large variety of pore size is due to the
internal interconnected structure of the ELR, where small pores are
able to merge to form larger pore structures.
Cell viability assay
A cell viability assay was performed for 2-week culturing of the ELR
hydrogel at 75 mg/ml when embedded with rMSCs (8 million/ml).
Assay data were recorded at different time points (0, 3, 6, 9, 12 and
15 days) in order to gain a better understanding of the metabolic
activity of the rMSCs. The cell viability analysis revealed an incre-
ment in metabolic activity, with a significant difference between
0 and 3 days and a constant increase from day 3 to 15 during the
culture process (Fig. 5). The biocompatibility demonstrated by our
ELR-based hydrogel is in agreement with similarly cross-linked
hydrogels previously studied [53]. Moreover, the curve trend of this
viability assay was in accordance with typical cell-growth behavior,
whereby the number of cells increases exponentially in the first part
of the culture, subsequently reaching a stable value.
Furthermore, the Dapi/Phalloidin analysis (Fig. 6) showed the
morphology of the rMSCs embedded in the 3D structure after
15 days of culture. Mesenchymal stem cells are pluripotent cells that
Figure 3. Rheological measurement for the ELR hydrogel at 37C and 75 mg/ml. (A) Strain dependence of the complex modulus (jG*j); (B) frequency dependence
of the storage (G0) and loss (G00) modulus; (C) frequency dependence of d. Each curve corresponds to the average of three different sample measurements
Figure 4. Representative SEM images for the ELR hydrogel at 75 mg/ml and different magnifications
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are able to differentiate into multiple cell types widely used in both
TE and regenerative medicine [41]. An extended and elongated cell
shape, with long cytoplasmic processes, can be seen in all the differ-
ent magnifications, thereby confirming colonization of the hydrogel
over 15 days. The cells showed a well-spread morphology, with
large extensions of their cytoskeleton actin filaments (green stained).
The pictures collected at different magnifications (Fig. 6A–C) help
to visualize both the homogeneous distribution of the rMSCs and
the colonization of the hydrogel at different focal points.
In vivo study results
Macroscopic observation of repaired cartilage
Rabbits were euthanized 4 months after the surgical procedure and
the performance of cartilage repair initially evaluated by macro-
scopic observation. The surface of the defects (Fig. 7) showed that
the defects in the central area of the trochlea were completely filled
at 4 months post-surgery in all animals from both groups (ELR
hydrogels and ELR hydrogels embedded with rMSCs). In addition,
the defects were covered by a white layer of fibrous tissue in both
groups. The regenerated tissue had a grayish color and could be eas-
ily recognized in both cases. As such, the regenerated tissue showed
a good integration with the surrounding tissue; indeed, there was no
clear boundary between the injured region and the surrounding
chondral tissue. The regeneration rate was further evaluated based
on macroscopic observation of the regenerated knee cartilage.
As noted above, the samples were evaluated using the ICRS gross
morphology assessment scale. Briefly, this gross evaluation takes
into consideration three parameters, namely the degree of defect re-
pair, integration with the border zone and macroscopic appearance
[54]. Each of these parameters is evaluated on a scale of 0–4, with a
total score ranging from 0 to a maximum of 12. The average score
for the ELR hydrogel group was 9.7 6 1.3, whereas the ELR hydro-
gel embedded with rMSCs scored 9.5 6 1.9 (Fig. 8A).
Histological analysis of repaired cartilage
Histological analyses were performed on the sections of the ELR-
based hydrogel embedded with rMSCs (Fig. 9) and on the ELR-
based hydrogel alone (Fig. 10). For histological analysis, all the sec-
tions were stained with H/E, Picro-Sirius Red Stain and Safranin-O/
Fast Green, for morphological evaluation and detection of collagen
and GAGs, respectively.
Histological analysis of the ELR-based hydrogel embedded with
rMSCs (Fig. 9) shows the absence of the hydrogel and that de novo
bone tissue formation is present. It can also be seen that the new
bone tissue exhibits the same porous and morphological structure as
the native surrounding tissue. The upper bone region (underneath
the cartilage layer) shows a less intense staining due to the degrada-
tion of the hydrogel combined to the uncompleted regeneration of
the bone layer. Moreover, the collagen staining has the same inten-
sity when comparing the regenerated cartilage with the native one.
The regenerated cartilage layer also contained small egg-shaped
cells, which is typical of the fibrocartilage-like tissue. Moreover, al-
though GAG staining revealed glycosaminoglycan’s production and
Figure 5. Cell viability test of a 3D ELR gel (75 mg/ml) embedded with rMSCs
at different time points (****P< 0.0001)
Figure 6. Optical microscope images of hydrogel colonization by rMSCs after culture for 15 days. Pictures collected at different magnifications (A–C)
Figure 7. Macroscopic appearance of defects in the trochlear groove (4 mm in
diameter) at 4 months post-surgery. (A) ELR-based hydrogel embedded with
rMSCs; (B) ELR-based hydrogel alone. Defects are indicated with a black
dashed line
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secretion in the cartilage layer, metachromatic Safranin-O staining
appeared to be less intense for the regenerated cartilage than for the
surrounding cartilage. Furthermore, although the regenerated tissue
at the articular surface of the samples exhibited an adequate thick-
ness in comparison with the adjacent non-injured articular cartilage,
the tissue had a fibrotic appearance. Finally, the subchondral bone
was mostly regenerated.
The first aspect that can be seen from the histological analysis of
the ELR-based hydrogel alone (Fig. 10) is the continued presence of
the hydrogel within the created defect. Although the hydrogel
remained intact in the inner part, it started to degrade from the pe-
riphery toward the center of the hydrogel. H/E staining clearly
showed a difference between native bone tissue and the hydrogel. In
addition, in the boundary area of the hydrogel, a higher concentra-
tion of cells (revealed by the higher intensity of the staining) enrolled
in degradation of the hydrogel and in de novo formation of bone tis-
sue can be seen. Safranin-O staining revealed the presence of proteo-
glycan in the relatively thin repaired tissue. In addition, collagen
staining indicated that the new tissue secretes an extracellular ma-
trix. Histological staining revealed a columnar arrangement of the
chondrocytes (typical of native cartilage) in the regenerated carti-
lage. The peripheral migration of these types of cells from the sur-
rounding tissue toward the defect area displayed a smooth and
regular surface of the regenerated cartilage, which exhibited a com-
plete integration with the adjacent non-injured cartilage. Moreover,
the regenerated cartilage showed no structural differences with re-
spect to healthy cartilage.
The section of the ELR-based hydrogel embedded with rMSCs
and the section of the ELR-based hydrogel alone were further ana-
lysed by immunohistochemistry with primary antibody anti-
collagen type I (fibrocartilage) and anti-collagen type II (hyaline car-
tilage), for detection of different types of collagen previously
revealed by the general Picro-Sirius stain.
In the case of the ELR-based hydrogel embedded with rMSCs
(Fig. 11), no collagen type II was detected in the regenerated carti-
lage. This result is in accordance with the histological analysis
Figure 8. ICRS macroscopic assessment scale. (A) Gross morphology assessment; (B) histological and immunohistochemical assessment. Values are expressed
as mean 6 standard deviation (n¼10)
Figure 9. Representative histological staining of repaired cartilage for ELR-based hydrogel with rMSCs
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previously described, where a non-columnar arrangement of chon-
drocytes was revealed. The presence of collagen type II in the native
cartilage ensures a correct staining performed for collagen type II.
Moreover, the staining for collagen type I appears in a spot-like dis-
tribution throughout the section, possibly due to high exposure to
this antibody, which is the signal for the non-appearance of collagen
type I in the regenerated area. We can, therefore, conclude that the
regenerative tissue in the ELR-based hydrogel embedded with
rMSCs was mainly fibrous tissue with a small amount of hyaline-
like tissue.
Notably, in the case of the ELR-based hydrogel alone (Fig. 12), a
marked production of collagen type II revealed the presence of hya-
line cartilage in the regenerated layer. In addition, this result is in
accordance with the histological analysis described previously,
which exhibited a columnar disposition of the chondrocytes.
Moreover, the immunohistochemistry study revealed how the chon-
drocytes involved in the regeneration process did not produce colla-
gen type I, showing the absence of fibrocartilage.
As reported above, the samples were evaluated according to the
ICRS visual histological assessment scale. The resulting score ranges
from 0 to a maximum of 18, with the final score being the sum of
six parameters, namely surface, matrix, cell distribution, cell popu-
lation viability, subchondral bone and cartilage mineralization.
Each of these parameters is given a value from 0 to 3. The average
score in the ELR hydrogel group was 11.4 6 3.1, whereas the ELR
hydrogel embedded with rMSCs scored 11.3 6 3.3 (Fig. 8B).
Figure 10. Representative histological staining of repaired cartilage for the ELR-based hydrogel alone
Figure 11. Representative immunohistochemistry study with anti-collagen type I and II for the cartilage regenerated using ELR-based hydrogels with rMSCs
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Discussion
It is well known that articular cartilage has a limited regeneration
capacity after disease or trauma and that fibrocartilage is produced
where the cartilage regeneration takes place [55, 56]. This type of
cartilage can easily degenerate and develop into osteoarthritis [57].
Considering that the clinical treatment of defective cartilage remains
problematic [58], the purpose of surgery is to regenerate the chon-
dral defects in order to obtain a structurally and biomechanically
competent hyaline cartilage. From a functional point of view, clini-
cal treatments are not able to promote the proper regeneration of
cartilage defects; TE represents a new approach for articular carti-
lage repair [51], it consists in reconstructing living tissue by associat-
ing cells with biomaterials. The 3D structure of the biomaterial
plays a supporting role for the cells, thus helping them to proliferate
under physiological conditions [59]. The application of new materi-
als in tissue-engineered scaffolds has received particular interest
[60], and several studies have demonstrated how bioinspired materi-
als can simulate the physiological characteristics, thereby enhancing
the biological properties of the scaffold [61–63]. In this study, we
have designed and developed an ELR-based hydrogel composed by
VKVx24-cyclo, REDV-N3 and HRGD6-N3, as reported in Fig. 1.
The specific composition of the ELR-based construct has been previ-
ously investigated by Staubli et al. demonstrating a good composi-
tion of the hydrogel tailored for a TE study; indeed, whereas the
ELR VKV counterpart gives stability to the hydrogel, the combina-
tion of ELRs containing RGD sequence and elastase target domain
is crucial for cell infiltration and material colonization [64]. In
the light of this previous study, we designed our ELR hydrogel to
contain 25% of an ELR bearing the elastase target domain, thus
allowing a slower degradation of the scaffold. Moreover, it has
to be taken into account that natural polymers showed some limita-
tions in terms of mechanical integrity. Indeed, both collagen and
hyaluronic acid have a short lifetime due to degradation by matrix
metalloproteinases [65].
The composition of the hydrogel permits immediate gelation by
click chemistry as it has been demonstrated by González et al. [53],
thus conferring the benefit of being an injectable scaffold on our
system. The mechanical features of the scaffold are a crucial factor
affecting cartilage repair. As it has been demonstrated, chemical
cross-linkable ELR hydrogels having similar Molecular Weight to
our hydrogel [53, 66] showed no dependence between the swelling
ratio and the concentration for the range 50–150 mg/ml at 37C,
maintaining a swelling ratio below 2. On the other hand, the hydro-
gel’s concentration directly influences the mechanical properties of
the hydrogel. Considering the remarkable results obtained in the ap-
plication of this material at a concentration of 75 mg/ml in TE [28],
we decided to use our hydrogel at the same concentration. The rheo-
logical characterization of the ELR hydrogel at 75 mg/ml showed a
complex modulus of around 1 kPa, which is in accordance with the
elastic modulus of many native tissues [67] and with the mechanical
features of efficient scaffolds for TE applications [53, 64].
Moreover, the low values of d obtained for the ELR hydrogel agree
with the viscoelastic behavior demonstrated in the cartilage layer
[68]. As it has been reported above, the d is the phase angle between
the applied stimulus and the corresponding response as a function of
strain amplitude or frequency; the constant values of d calculated
demonstrated a highly elastic energy storing hydrogel at different
frequency values. It is important to take into account that articular
cartilage has unique biological properties (such as permeability and
viscoelasticity) when compared with other cartilage [69]. Indeed,
the structure and physiochemical properties of articular cartilage are
similar to those of hydrogels. SEM analysis revealed the morphology
of the hydrogel at 75 mg/ml, which shows an interconnected struc-
ture with adequate porosity and permeability, along with an appro-
priate pore size for the creation of a 3D scaffold embedded with
rMSCs. The pore size determines the exchange of nutrients and
waste products because of the void spaces where the cells are seeded
and influences de novo secretion of ECM [70]. Moreover, the fluid
movement in the hydrogel determined by the pore size plays a fun-
damental role in the regeneration process; in order to guarantee a
good regeneration, it should be similar to that for native tissue [71].
Cells play a critical role in the regeneration process; when incor-
porated into a biomaterial they can enhance tissue regeneration.
Although it is well known that chondrocytes only form 1–5% vol-
ume of the mature articular cartilage [72], it has been demonstrated
that a higher MSCs seeding density results in better chondrogenesis
[73–76]. We selected a seeding density of 8106 cells/ml consider-
ing the outcomes of previous studies performed with a similar cell
Figure 12. Representative immunohistochemistry study with anti-collagen type I and II for the cartilage regenerated using the ELR-based hydrogel alone
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density [77, 78]. The cell viability analysis revealed an increment in
metabolic activity throughout the 15 days of culture, thus showing
that the ELR-based hydrogel is a biocompatible scaffold for cell
repopulation. Moreover, considering that the highest increase of
metabolic activity was recorded within the first 3 days, the rMSCs
appear to be more active when the hydrogel has a lower cell density,
reaching a more quiescent state once the hydrogel starts to be
repopulated.
The Dapi/Phalloidin analysis showed the morphology of the
rMSCs embedded in the 3D structure after 15 days of culture. The
specific composition of the ELR hydrogel, which contains RGD and
REDV bioactive domains, permitted efficient cell attachment.
Indeed, the colonization process indicates that this specific composi-
tion of the scaffold is able to support the culture of embedded cells.
Assuming that a suitable scaffold for TE should mimic the ECM
functional properties, the in vitro study showed an adequate compo-
sition of the ELR hydrogel, thereby facilitating the encapsulation of
reparative cells into a 3D matrix [79]. Moreover, the elastase target
domain (VGVAPG sequence) fosters cell-mediated remodeling of
the artificial scaffold. In addition, cell proliferation, and thus coloni-
zation of the scaffold, is guaranteed because of the action of pro-
teases during the synthesis of new extracellular matrix.
In this study, we tested the ELR-based hydrogel embedded with
rMSCs and the ELR-based hydrogel alone to repair cartilage defects
in vivo. Macroscopic examination of the surface of the defects
(Fig. 7) showed that the defects were completely covered 4 months
after the surgery in all animals. The scores on the ICRS gross mor-
phology assessment scale for the two hydrogels are practically the
same, thus suggesting that both groups aid cartilage regeneration,
allowing the defects to be filled. However, histological analysis of
the dissected knees was necessary to determine which type of carti-
lage was regenerated, and whether the gel was fully replaced by
newly formed tissue.
However, in contrast to the macroscopic evaluation, the histo-
logical analysis showed two different responses from the two groups
as regards tissue, bone and cartilage. For the bone area, in the case
of ELR-based hydrogel alone, a large quantity of intact hydrogel
was present, whereas in the rMSCs group no intact hydrogel was
present. In the boundary area of the ELR-based hydrogel alone, it
was observed a higher concentration of cells enrolled in degradation
of the hydrogel and in de novo formation of bone. This inflamma-
tory cells infiltration in the hydrogel and the consequent degradation
of the scaffold was mainly due to the presence of the elastase target
domain. This behavior is in accordance with previous studies per-
formed with ELR-based hydrogel containing protease target
domains [64]. Moreover, in this case, the degradation came only
from the surrounding tissue and the tissue-replacement process was
not complete at 4 months post-surgery.
Finally, it is important to take into account that the rejection of
engraftment depends essentially by the host immune response,
whereby the proportion between inflammation and pro-resolution is
the key for successful implantation of the engineered tissue [64, 80].
In contrast, the group treated with the ELR-based hydrogel contain-
ing rMSCs showed a much more marked degradation. Indeed, in
that case, the degradation occurred both from the surrounding tissue
and from the cells embedded in the hydrogel. For the cartilage layer,
the histological and immunohistochemistry staining showed how
the group treated with the ELR-based hydrogel alone exhibited bet-
ter cartilage regeneration compared to the group treated with the
ELR-based hydrogel containing rMSCs. The group with no rMSCs
exhibited all the typical features of hyaline cartilage, such as the
columnar disposition of chondrocytes, excellent GAG staining and
the presence of collagen type II, that provides the tensile ability to
the cartilage layer [8]. Moreover, the absence of fibrocartilage con-
firms that ELR hydrogel is an attractive solution for cartilage regen-
eration. Although there is no significant difference in the scores for
the ICRS visual histological assessment scale, we can conclude that
the ELR-based hydrogel containing rMSCs leads to faster regenera-
tion of the bone tissue and worse cartilage regeneration. In contrast,
the ELR-based hydrogel alone enhanced the quality of the regener-
ated cartilage but the degradation of the hydrogel in the bone area
was not complete. During the repair process, the hydrogel was grad-
ually replaced by de novo tissue formation. Starting with the as-
sumption that the purpose of this scaffold is to promote the bone
and cartilage formation instead than merely substitute the tissue, it
is important to evaluate either the capacity to support the cell adhe-
sion and proliferation and the mechanical stability at the defect site.
A crucial aspect was played by the 25% of the ELR containing the
elastase domain, which allows for degradation of the hydrogel. As
such, it could be of interest to test other hydrogel candidates that
have different percentages of protease sequences in order to synchro-
nize bone regeneration and cartilage repair. Moreover, another im-
portant aspect to take into consideration is the proportion between
the RGD sequence and the REDV domain; as discussed recently by
Flora et al., the ratio between these two bioactive domains can tailor
the selectivity of the biomaterial toward specific cell lines [81].
Generally speaking, the degradation time of materials should match
the production speed of the new tissue. Rapid degradation of the
scaffold affects both repopulation of the hydrogel by rMSCs and
their differentiation or the colonization of chondrocytes from the sur-
rounding native tissue. A slow degradation could hinder cell prolifera-
tion and matrix secretion [82, 83], although we found that, a high
density of rMSCs in our scaffold increased the regeneration of fibro-
cartilage instead of hyaline cartilage. Another important aspect that
has to be taken in consideration is the cell–cell contact in the hydrogel,
which regulates not only the cell behavior and the MSCs differentia-
tion, but it is also crucial for the development of the tissue architec-
ture. This parameter is strongly correlated to the cells density of the
hydrogel. One of the major challenges for osteochondral repair is to
obtain regenerated cartilage with adequate mechanical properties.
This outcome is not completely fulfilled by synthetic hydrogels, which
do not show the biological features of ECM and tend to regenerate
fibrocartilage [84].
Our ELR hydrogel has been shown to have an adequate compo-
sition, with tunable degradation rate and adhesion behavior, exhib-
iting a good balance between the degradation rate and adhesion
behavior, and allowing for the colonization of chondrocytes
with an optimal secretion of extracellular matrix-collagen type II
at the periphery of the hydrogel. Moreover, we observed excellent
cartilage repair without the need for cellular implantation, which
is a significant advantage in terms of eluding all the technical and
ethical complications of cell implantation. Finally, these results are
promising as regards the testing of other ELR-based hydrogels with
higher degradation rates for bone regeneration, thus leading to an
optimal system for osteochondral repair.
Conclusion
One of the biggest challenges in TE is to discover a new biomaterial
that guarantees an adequate regeneration of either bone or cartilage
tissue. In this study, we took advantage of the recombinant DNA
technique to develop a bioactive ELR-based hydrogel with a specific
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composition as an injectable scaffold for osteochondral repair.
The specific composition of this hydrogel allowed for faster bone re-
generation when embedded with rMSCs compared to the injection of
the hydrogel alone. Similarly, the specific composition of this
bioactive hydrogel allowed for the infiltration and the recruiting of
native cells (chondrocytes) to promote the repair and remodeling of
articular cartilage. According to the outcomes revealed by this study,
a promising therapy for osteochondral repair could be the develop-
ment of a bilayer system based on ELR hydrogels. This system would
consist of a bottom layer composed by the hydrogel embedded with
MSCs, which fill the subchondral bone cavity, whereas the upper
layer would be composed by the hydrogel itself. In conclusion, our
bioactive ELR-based hydrogel alone was able to resemble native tissue
in terms of hyaline cartilage content and the absence of fibrocartilage,
thus proving to be a promising scaffold for cartilage repair.
Supplementary data
Supplementary data are available at REGBIO online.
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